---
$id: https://graph.org.ai/products/commodity/51161535
$type: Product
source: UNSPSC
code: "51161535"
title: "Dimabefylline"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dimabefylline

**UNSPSC Code**: 51161535
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula C16H19N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L6V4Z7SX7S, chemically known as 7-(p-dimethylaminobenzyl)-1,3-dimethylxanthine but generally known as dimabefylline, which bears US NIH Compound Identifier 71646. European Medicines Agency schedules Dimabefylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07149MIG. The term DIMABEFYLLINE is an International Non-Proprietary Name. DIMABEFYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dimabefylline under HS 29395900 and SITC 54145. As of Q4 2014, DIMABEFYLLINE remains the US FDA Preferred Term for this commodity. Dimabefylline bears US NLM identifiers UMLS ID C1880329 and NCI Concept Code C65392. SMILES: O=C1N(C(=O)N(C2NCN(C12)CC1CCC(N(C)C)CC1)C)C.

